Hirawat Samit bought PCRX

January 27, 2026 · Form 4 insider transaction

Hirawat Samit bought 39,291 shares of Pacira BioSciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
39,291
Price
$0.00
Total value
N/A
Role
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 27, 2026
Filing dateJanuary 29, 2026
Shares owned after39,291
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

View the original Form 4 on SEC EDGAR
Hirawat Samit bought PCRX: January 27, 2026 | Insider Trading Screener